PTK2 and breast carcinoma: As indicated above, the discovery that FAK suppression potentiated response to mTORCi was only uncovered when utilizing mouse models of breast cancer and drug synergy was not detected in vitro using extensive Chou–Talalay analyses (Supplementary Figure S3 and data not shown) [71,72].